Enbio-Life Biotechnology & Medical

Enbio-Life Biotechnology & Medical (officially known as Yusheng Pharma) is a Taiwanese biotechnology and pharmaceutical company specializing in the development, marketing, and distribution of clinically-validated healthcare products. Founded in 2003 and headquartered in Taichung, the company focuses on therapeutic areas such as dermatology, gastroenterology, and metabolic health. It is best known for its strategic partnership with the Canadian firm Advitech to distribute Dermylex (marketed as Domilex in Taiwan), a whey-derived bioactive peptide treatment for mild to moderate psoriasis. Enbio-Life's portfolio also includes a range of nutritional supplements and functional foods, such as bitter melon peptides for blood sugar regulation and high-purity fish oils. The company serves as a bridge for international biotech firms entering the Asian market, providing regulatory support and clinical trial management to ensure product efficacy in local populations.